New gel aims to reignite sexual arousal in women
NCT ID NCT06651541
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This Phase 2 study tests a gel called BZ371A on 174 women with sexual arousal disorder. The gel is applied before sexual activity to see if it increases arousal, desire, and lubrication compared to a placebo. The goal is to find a safe and effective option for women struggling with arousal.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- BZ371A gel
- What this could lead to
- If successful, this gel could offer a new topical treatment to help women with sexual arousal disorder experience increased arousal during sexual activity.
- What could go wrong
- This is an early Phase 2 trial with only 174 participants, so results may not confirm effectiveness or safety. The placebo effect is also a factor in sexual health studies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FEMALE SEXUAL AROUSAL DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ambulatório Jenny Farias do Hospital das Clínicas da UFMG
Belo Horizonte, Brazil
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Nerve stimulation may ease sexual dysfunction and back Pain—Trial puts it to the test
- Biofeedback training aims to restore sexual health in cervical cancer survivors
- Shockwaves or magnets? new trial tests two therapies for Women's sexual health
- New surgery aims to fix pelvic organ prolapse with fewer complications